Delivery Order SPE2DB20D3103-SPE2DB21FP8P5

Award Date 8/11/21
Potential Completion Date 8/12/21
Potential Value $9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Carvedilol ER 80 mg capsules to the Defense Logistics Agency (DLA). The $1,432.79 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 6, 2024. The contract has an ultimate completion date of November 7, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA). The $3,575.71 firm-fixed-price delivery order, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA). The $7,482.60 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. The contract has an ultimate completion date of March 27, 2023 and was not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract, valued at $10,238.23, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, which is a major pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order, with a completion date of March 25, 2024. Amerisourcebergen Drug...
This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA). The $1,584.34 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. The...
This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The $38,953.86 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 16, 2024 with an ultimate completion date of October 17, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The $3,492.57 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical division. This IDC serves as the primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical...
This federal contract award is for the delivery of Carvedilol ER 80 mg capsules, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $20,923.46 firm-fixed-price contract has an ultimate completion date of April 21, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of Carvedilol ER 10 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price of $27,708.46 and an ultimate completion date of September 21, 2023. The award was made without any set-aside designation, indicating open competition....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FP8P5
    Delivery Order

This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $9,043.42 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 11, 2021. The contract has an ultimate completion date of August 12, 2021 and does not have any set-aside designations, indicating open competition.

Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities to support the healthcare needs of the military and veteran populations. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.

Generated 2/27/25, 12:08 PM